Biotech componentsMolecule

Products 11 to 20 of 38

Endocannabinoids for intestinal infection treatment by University of Texas Southwestern Medical Center
Biotech components: Molecule + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (4 years ago)
Date last modified: 2020/12/18 14:39 (4 years ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: N/A
fiberTyping by Applied DNA Sciences
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/01/30 11:57 (6 years ago)
Known funding amount: 19,800,000 USD
Funding types: Shareholder Investment
Industry: Security
Market status: Under Development
Organization type(s): Public Company
Product categories: Forensic Tagging
Production process: Closed Production
Source: NASEM Database
Trading symbol: APDN (NASDAQ)
Value chain stage: Finished Product
Gene-edited Produce by Pairwise Plants
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/08 14:49 (6 years ago)
Known funding amount: 125,000,000 USD
Funding types: Private Funding + Shareholder Investment
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Plant
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Animal + Molecule
Business models: N/A
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/04/01 10:01 (6 years ago)
Date last modified: 2019/04/12 09:36 (5 years ago)
Known funding amount: N/A
Funding types: N/A
Industry: Medical
Market status: Under Development + More information needed
Organization type(s): N/A
Product categories: N/A
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
PCR-produced linear DNA by Applied DNA Sciences + LineaRx
Biotech components: Molecule
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial + Government
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/01/30 11:54 (6 years ago)
Known funding amount: 19,800,000 USD
Funding types: Shareholder Investment
Industry: Science
Market status: On the market
Organization type(s): Public Company
Product categories: Research
Production process: Closed Production
Source: NASEM Database
Trading symbol: APDN (NASDAQ)
Value chain stage: Platform
Mast-MO (antibiotic wasp venom) by University of Pennsylvania’s Perelman School of Medicine
Biotech components: Animal + Bacteria + Molecule
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:40 (4 years ago)
Date last modified: 2020/12/18 14:40 (4 years ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Input
Biotech components: Molecule
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:39 (4 years ago)
Date last modified: 2020/12/18 14:39 (4 years ago)
Known funding amount: N/A
Funding types: University
Industry: Medical
Market status: Early Stage Concept
Organization type(s): University
Product categories: Medicine + Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: N/A
Myristoyl Glutamate (Surfactant) by Modular Genetics, Inc.
Biotech components: Molecule
Business models: B2B
Country of production: USA
Country of distribution: USA
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/08/30 11:49 (6 years ago)
Known funding amount: 1,121,998 USD
Funding types: Private Funding + University + Government
Industry: Health
Market status: Under Development
Organization type(s): Private Company
Product categories: Medical Treatment
Production process: Open Release
Source: SynBio Database
Trading symbol: N/A
Value chain stage: Finished Product
NanoHeal by RISE PFI AS
Biotech components: Molecule
Business models: B2B
Country of production: Norway
Country of distribution: Norway
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/08 14:51 (6 years ago)
Known funding amount: N/A
Funding types: Government + University
Industry: Health
Market status: Early Stage Concept
Organization type(s): Research Institution
Product categories: Medical Treatment
Production process: Closed Production
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
OG716: Lantibiotics by Oakbio + Oragenics
Biotech components: Molecule
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:12 (5 years ago)
Date last modified: 2019/09/12 15:16 (5 years ago)
Known funding amount: N/A
Funding types: Private Funding + Shareholder Investment
Industry: Medical
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Medicine
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product